503312-32-1

Upstream product

• 15548-45-5 (2S,3S,4S,5S,6R)-2-benzyloxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol 
• 108549-23-1 Dibenzyl N,N-diisopropylphosphoramidite 
• 503312-29-6 2,3,4,6-tetra-O-pivaloyl-α-D-mannopyranose 
• 3282-30-2 pivaloyl chloride 

Relevant academic research and scientific papers

TREATMENT OF CONGENITAL DISORDERS OF GLYCOSYLATION (CDG) USING MANNOSE

The invention relates to mannose 1-phosphate derivatives and to pharmaceutical or dietary agents, which contain the same and which are used for treating disorders of glycosylation and, in particular, for treating CDG-1a. These derivatives comprise the fol

Membrane-permeant derivatives of mannose-1-phosphate

For treatment of congenital disorder of glycosylation type Ia (CDG-Ia) membrane-permeant derivatives of mannose-1-phosphate are required. Employing biologically cleavable phosphate protecting groups advantageous precursor derivatives could be synthesized